Fezolinetant effect on vasomotor symptoms due to menopause in women unsuitable for hormone therapy
EndocrinologiaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- Current medical research and opinion
- Publicado em
- 5 mar 2025
- Citações
- 10
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Fezolinetant effect on vasomotor symptoms due to menopause in women unsuitable for hormone therapy
Nanette Santoro, Genevieve Neal-Perry, Petra Stute, Martin Blogg, Shayna Mancuso, Antonia Morga, Faith D Ottery, Emad Siddiqui
Descritores MeSH
- Menopause
- Vasomotor System
- Hot Flashes
- Estradiol
- Female
- Adult
- Middle Aged
- Progesterone
- Humans
- Aged
Veja também
Estudos relacionados
- Efficacy and safety of elinzanetant in vasomotor symptoms associated with menopause: A meta-analysis of randomized controlled trials
- Elinzanetant: Efficacy and safety in the management of vasomotor symptoms in postmenopausal women, a systematic review and meta-analysis with grading of recommendations assessment, development, and evaluation assessment
- Pharmacological Treatments for Menopausal Vasomotor Symptoms: A Systematic Review and Bayesian Network Meta-Analysis of Efficacy and Safety
- Efficacy and safety of fezolinetant and elinzanetant for vasomotor symptoms in postmenopausal women: A systematic review and meta-analysis